METHOD FOR SELECTION OF REHABILITATION THERAPY FOR PATIENTS WITH CHRONICAL CHOLECYSTITIS IN REMISSION PHASE Russian patent published in 2009 - IPC A61K31/722 A61K31/685 A61K33/10 A61P1/16 A61K35/10 A61K35/08 A61K33/12 A61N1/30 

FIELD: medicine; gastroenterology.

SUBSTANCE: after patient has been diagnosed with normal values of serum lipids, apolipoproteid B and balanced processes of lipid peroxidation (POL) and phosphatidyl serine (PS) that is less or equal to 10.4%, content of sphingomyelins (SP) from 24.1% to 27.6%, value of phosphatidyl ethanolamine (PE) equal or more than 29.2%, ratio of phosphatidyl choline PC/PE below 1.2, and also index of fatty acids unsaturation (IFAU) from 160.1 to 165.7, hypolipidemic dietotherapy (HD) is realised with enterosorbent hitamine or with taking of carbonated mineral water (CMW) and electrophoresis of mud extraction (EME) to liver area. If total cholesterol (TC) value is 5.0 -5.3 mM/l, cholesterol of low density lipoproteins (CLDL) is 2.9-3.3 mM/l and triglycerides make ≤0.9 mM/l, apolipoproteid B is ≤ 61.0 mg/dl, and (POL) lipid peroxidation processes are balanced with antioxidant protection (AOP) on the background of phosphatidyl serine content of 10.5%-13.6%, sphingomyelines content is ≤24.1% and IFAU makes 150.-160.0, HD is prescribed in complex with essential phospholipids (EP) or with enterosorbent hitamine with taking of HCMW and EME to liver area. If TC content is ≥5.4 mM/l, CLDL is ≥3.4 mM/l, CLDL is ≥1.7 mM/l, apolipoproteid B makes 112.0-183.0 mg/dl and total antioxidant activity of blood is ≤49% in combination of PC of 32.9%-33.4%, PE 27.6%-29.1%, ratio of PC/PE of 1.2 and IFAU is ≤150.4, HD is prescribed with inclusion of EP.

EFFECT: differentiated adequate pathogenetically oriented lipid-correcting therapy for this contingent of patients.

1 tbl, 1 ex, 1 dwg